09:00:59 EST Tue 07 Feb 2023
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Entheon Biomedical Corp
Symbol ENBI
Shares Issued 59,089,266
Close 2022-11-30 C$ 0.03
Recent Sedar Documents

Entheon to cease HaluGen, Lobo genetic test kit sales

2022-11-30 18:16 ET - News Release

Mr. Timothy Ko reports

ENTHEON PROVIDES CORPORATE UPDATE ON HALUGEN LIFE SCIENCES AND LOBO GENETICS

Entheon Biomedical Corp. is providing an update on its two wholly owned subsidiaries, HaluGen Life Sciences Inc. and Lobo Genetics Inc.

As part of Entheon's continued efforts to refocus resources, Entheon will be ceasing sales of HaluGen, and Lobo and HaluGen direct-to-consumer (DTC) genetic testing kits to reduce operational costs. Existing customers can continue to view their genetic test results at the HaluGen and the Lobo websites.

About HaluGen Life Sciences Inc.

HaluGen has developed a DNA testing and personalized psychedelic prescreening platform that provides genetic, personal and familial insights to better inform the psychedelic experience, with the goal of improving patient care and reducing side effects and risk. HaluGen's genetic-based psychedelic prescreening platform helps evaluate an individual's overall sensitivity and risk profile when using hallucinogenic drugs. This platform is the first of its kind with test results within days.

About Lobo Genetics Inc.

Lobo is a personalized genetic company with a direct-to-consumer platform currently being used in both the psychedelic and cannabis spaces to provide personalized insights into an individual's response to hallucinogenic and psychoactive drugs.

About Entheon Biomedical Corp.

Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.

We seek Safe Harbor.

© 2023 Canjex Publishing Ltd. All rights reserved.